The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles

Show Notes

The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles by Blood Advances Community Conversations

What is Blood Advances Community Conversations?

Blood Advances, the open access journal of the American Society of Hematology, provides an open international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology and related sciences.